Cargando…
Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids
Peptide nucleic acids (PNAs) have emerged as one of the most versatile tools with a wide range of biomedical applications including antisense, antimiR, antigene, as well as site-specific gene editing. The application and potential of PNAs has been limited due to low solubility and poor cellular upta...
Autores principales: | Malik, Shipra, Slack, Frank J, Bahal, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596289/ https://www.ncbi.nlm.nih.gov/pubmed/33145187 http://dx.doi.org/10.1016/j.mex.2020.101115 |
Ejemplares similares
-
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics
por: Pradeep, Sai Pallavi, et al.
Publicado: (2023) -
Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids
por: Malik, Shipra, et al.
Publicado: (2021) -
Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
por: Malik, Shipra, et al.
Publicado: (2019) -
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities
por: Quijano, Elias, et al.
Publicado: (2017) -
Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids
por: Putman, Rachael, et al.
Publicado: (2022)